MHC class I antigen processing pathways

Human Immunology

Volumn 54, Issue 2, 1997, Pages 91-103

  Maffei, Antonella ^a   Papadopoulos, Kyriakos ^b   Harris, Paul E ^b  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; GLYCOPROTEIN; HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; PROTEASOME; PROTEIN PRECURSOR;

ANTIGEN PRESENTATION; COMPLEX FORMATION; HUMAN; PRIORITY JOURNAL; REVIEW;

ANTIGEN PRESENTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDES;

EID: 0030806053     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00084-0     Document Type: Review

References (124)

1. Borkman PJ, Parham P: Structure, function and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 59:253, 1990.
2. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1996. Hum Immunol 53:98, 1997.
3. Bouvier M, Wiley DC: Importance of peptide amino and carboxyl terminii to the stability of peptide binding. Science 265:398, 1994.
4. Hunt DF, Henderson RA, Shabanowicz J, Sakaguchi K, Michel H, Sevilir N, Cox A, Appella E, Engelhard VH: Characterization of peptides bound to class I MHC molecules HLA A2.1 by mass spectrometry. Science 255: 1261, 1992.
5. Falk K, Rotzschke O: Consensus motifs and peptide ligands of MHC class I molecules. Semin Immunol 5:81, 1993.
6. Frumento G, Harris PE, Gawinowics MA, Suciu-Foca N, Pernis B: Sequence of a prominent 16 residue self-peptide bound to HLA-B27 in a lymphoblastoid cell line. Cell Immunol 152:623, 1993.
7. Guo HC, Jardetzky TS, Garrett TPJ, Lane WS, Strominger JL, Wiley DC: Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360:364, 1992.
8. Collins EJ, Garboczi DN, Wiley DC: Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature 371:626, 1994.
9. Madden DR: The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 13:587, 1995.
10. Rammensee HG, Friede T, Stevanovic S: MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178, 1995.
11. del Guercio MF, Sidney J, Hermanson G, Perez C, Grey HM, Kubo RT, Sette A: Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol 154:685, 1995.
12. Parker KC, Shields M, DiBrino M, Brooks A, Coligan JE: Peptide binding to MHC class I molecules: implications for antigenic peptide prediction. Immunol Res 14:34, 1995.
13. Parker KC, Bednarek MA, Coligan JE: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152:163, 1994.
14. DiBrino M, Tsuchida T, Turner RV, Parker KC, Coligan JE, Biddison WE: HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J Immunol 151:5930, 1993.
15. Germain RN, Margulies DH: The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 11:403, 1993.
16. Monaco JJ: A molecular model of MHC class-I-restricted antigen processing. Immunol Today 13:173, 1992.
17. Bergeron JJ, Brenner MB, Thomas DY, Williams DB: Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. Trends Biochem Sci 19:124, 1994.
18. Hammond C, Helenius A: Quality control in the secretory pathway. Curr Opin Cell Biol 7:523, 1995.
19. Williams DB, Watts TH: Molecular chaperones in antigen presentation. Curr Opin Immunol 7:77, 1995.
20. Vassilakos A, Cohen-Doyle MF, Peterson PA, Jackson MR, Williams DB: The molecular chaperone calnexin facilitates binding and assembly of class I histocompatibility molecules. EMBO J 15:1495, 1996.
21. Scott JE, Dawson JR: MHC class I expression and transport in a calnexin-deficient cell line. J Immunol 155: 143, 1995.
22. Balow JP, Weissman JD, Kearse KP: Unique expression of major histocompatibility complex class I proteins in the absence of glucose trimming and calnexin association. J Biol Chem 270:29025, 1995.
23. Raposo G, van Santen HM, Leijendekker R, Geuze H, Ploegh HL: Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER-Golgi intermediate compartment. J Cell Biol 131:1403, 1995.
24. David V, Hochstenbach F, Rajagopalan S, Brenner MB: Interaction with newly synthesized and retained proteins in the endoplasmic reticulum suggests a chaperone function for human integral membrane protein IP90 (calnexin). J Biol Chem 268:9585, 1993.
25. Sonnichsen B, Fullenkrug J, Van PN, Diekmann W, Robinson DJ, Mieskes G: Retention and retrieval: both mechanisms cooperate to maintain calreticulin in the endoplasmic reticulum. J Cell Sci 107:2705, 1994.
26. Sadasivan B, Lehner PJ, Ortman B, Spies T, Cresswell P: Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5:103, 1996.
27. DeMars R, Rudersdorf R, Chang C, Petersen J, Strandtmann J, Korn N, Sidwell B, Orr HT: Mutations that impair a post-transcriptional step in expression of HLA-A and -B antigens. Proc Natl Acad Sci USA 82: 8183, 1985.
28. Neefjes JJ, Momburg F, Hammerling GJ: Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 621:769, 1993.
29. Ortmann B, Androlewicz MJ, Cresswell P: MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368:864, 1994.
30. Grandea AG 3rd, Androlewicz MJ, Athwal RS, Geraghty DE, Spies T: Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 270:105, 1995.
31. Suh WK, Cohen-Doyle MF, Fruh K, Wang K, Peterson PA, Williams DB: Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264:1322, 1994.
32. Heemels MT, Ploegh HL: Generation, translocation and presentation of MHC class I-restricted peptides. Annu Rev Biochem 64:463, 1995.
33. Koopmann JO, Post M, Neefjes JJ, Hammerling GJ, Momburg F: Translocation of long peptides by transporters associated with antigen processing (TAP). Eur J Immunol 26:1720, 1996.
34. Schumacher TNM, Kantesaria DV, Heemels MT, Ashton-Rickardt PG, Shepherd JC, Fruh K, Yang Y, Peterson PA, Tonegawa S, Ploegh HL: Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator. J Exp Med 179:533, 1994.
35. Momburg F, Roelse J, Howard JC, Butcher GW, Hammerling GJ, Neefjes JJ: Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367:648, 1994.
36. Bacik I, Cox JH, Anderson R, Yewdell JW, Bennink JR: TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide. J Immunol 152:381, 1994.
37. Armandola EA, Momburg F, Nijenhuis M, Bulbuc N, Fruh K, Hammerling GJ: A point mutation in the human transporter associated with antigen processing (TAP2) alters the peptide transport specificity. Eur J Immunol 26:1748, 1996.
38. Obst R, Armandola EA, Nijenhuis M, Momburg F, Hammerling GJ: TAP polymorphism does not influence transport of peptide variants in mice and humans. Eur J Immunol 25:2170, 1995.
39. Androlewicz MJM, Creswell P: How selective is the transporter associated with antigen processing? Immunity 5:1, 1996.
40. van Endert PM, Riganelli D, Greco G, Fleischhauer K, Sidney J, Sette A, Bach JF: The peptide-binding motif for the human transporter associated with antigen processing. J Exp Med 182:1883, 1995.
41. Neisig A, Wubbolts R, Zang X, Melief C, Neefjes JJ: Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J Immunol 156:3196, 1996.
42. Hughes EA, Ortmann B, Surman M, Cresswell P: The protease inhibitor, N-acetyl-L-leucyl-L-leucyl-leucyl-L-norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum. J Exp Med 183:1569, 1996.
43. Elliott T, Willis A, Cerundolo V, Townsend A: Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J Exp Med 181: 1481, 1995.
44. Snyder HL, Yewdell JW, Bennink JR: Trimming of antigenic peptides in an early secretory compartment. J Exp Med 180:2389, 1994.
45. Roelse J, Gromme M, Momburg F, Hammerling G, Neefjes JJ: Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J Exp Med 180:1591, 1994.
46. Kleijmeer MJ, Kelly A, Geuze HJ, Slot JW, Townsend A, Trowsdale J: Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. Nature 357:342, 1992.
47. Bresnahan PA, Barber LD, Brodsky FM: Localization of class I histocompatibility molecule assembly by subfractionation of the early secretory pathway. Hum Immunol 53:129, 1997.
48. Tevethia SS, Tevethia MJ, Lewis AJ, Reddy VB, Weimman SM: Biology of simian virus 40 (SV40) transplantation antigen (TrAg) IX. Analysis of TrAg in mouse cells synthesizing truncated SV40 large T antigen. Virology 128:319, 1983.
49. Gooding LR, O'Connell KA: Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen. J Immunol 131:2580, 1983.
50. Bennik JR, Yewdell JW, Gerhard W: A viral polymerase involved in recognition of influenza vinis infected cells by a cytotoxic T clone. Nature 269:75, 1982.
51. Townsend ARM, Skehel JJ: The influenza A virus nucleoprotein gene controls the induction of both sub-type specific and cross-reactive cytotoxic T cells. J Exp Med 160:552, 1984.
52. Morrison LA, Lukacher A, Braciale VL, Fan DP, Braciale TJ: Differences in an antigen presentation to MHC class I and class II restricted influenza virus specific T lymphocyte clones. J Exp Med 163:903, 1986.
53. Moore MW, Carbone FR, Bevan MJ: Introduction of soluble protein into class I pathway of antigen presentation. Cell 54:777, 1988.
54. Townsend ARM, Bastin J, Gould K, Brownlee GG: Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence. Nature 324:575, 1986.
55. Rubin DM, Finley D: The proteasome: a protein-degrading organelle? Curr Biol 5:854, 1995.
56. Groettrup M, Soza A, Eggers M, Kuehn L, Dick TP, Schild H, Rammensee HG, Koszinowski UH, Kloetzel PM: A role for the proteasome regulator PA28alpha in antigen presentation. Nature 381:166, 1996.
57. Yang B, Hahn YS, Hahn CS, Braciale TJ: The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen. J Exp Med 183:1545, 1996.
58. Groettrup M, Soza A, Kuckelkorn U, Kloetzel P: Peptide antigen production by the proteasome: complexity provides efficiency. Immunol Today 17:429, 1996.
59. Harding CV, France J, Song R, Farah JM, Chatterjee S, Iqbal M, Siman R: Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway. J Immunol 155:1767, 1995.
60. Hisamatsu H, Shimbara N, Saito Y, Kristensen P, Hendil KB, Fujiwara T, Takahashi E, Tanahashi N, Tamura T, Ichihara A, Tanaka K: Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma. J Exp Med 183:1807, 1996.
61. Groettrup M, Kraft R, Kostka S, Standera S, Stohwasser R, Kloetzel PM: A third interferon-gamma-induced subunit exchange in the 20S proteasome. Eur J Immunol 26:863, 1996.
62. Gaczynska M, Rock KL, Spies T, Goldberg AL: Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc Natl Acad Sci USA 91:9213, 1994.
63. Seliger B, Hohne A, Knuth A, Bernhard H, Meyer T, Tampe R, Momburg F, Huber C: Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression. Cancer Res 56:1756, 1996.
64. Dick TP, Ruppert T, Groettrup M, Kloetzel PM, Kuehn L, Koszinowski UH, Stevanovic S, Schild H, Rammensee HG: Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86:253, 1996.
65. Finley D, Chau V: Ubiquitination. Annu Rev Cell Biol 7:25, 1991.
66. Muller S, Schwartz LM: Ubiquitin in homeostasis, development and disease. Bioessays 17:677, 1995.
67. Varshavsky A: The N-end rule. Cell 69:725, 1992.
68. Matthews JR, Hay RT: Regulation of the DNA binding activity of NF-kappa B. Int J Biochem Cell Biol 27:865, 1995.
69. Musti AM, Treier M, Bohman D: Reduced ubiquitindependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275:400, 1997.
70. Vassilev AP, Rasmussen HH, Christensen EI, Nielsen S, Celis JE: The levels of ubiquitinated histone H2A are highly upregulated in transformed human cells: partial colocalization of uH2A clusters and PCNA/cyclin foci in a fraction of cells in S-phase. J Cell Sci 108:1205, 1995.
71. Ciechanover A, DiGiuseppe JA, Bercovich B, Orian A, Richter JD, Schwartz AL, Brodeur GM: Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc Natl Acad Sci USA 88:139, 1991.
72. Gonen H, Smith CE, Siegel NR, Kahana C, Merrick WC, Chakraburtty K, Schwartz AL, Ciechanover A: Protein synthesis elongation factor EF-1 alpha is essential for ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu. Proc Natl Acad Sci USA 91:7648, 1994.
73. Gardner AM, Aviel S, Argon Y: Rapid degradation of an unassembled immunoglobulin light chain is mediated by a serine protease and occurs in a pre-Golgi compartment. J Biol Chem 268:25940, 1993.
74. Neefjes JJ, Smit L, Gehrmann M, Ploegh HL: The fate of the three subunits of major histocompatibility complex class I molecules. Eur J Immunol 22:1609, 1992.
75. Young J, Kane LP, Exley M, Wileman T: Regulation of selective protein degradation in the endoplasmic reticulum by redox potential. J Biol Chem 268:19810, 1993.
76. Shin J, Lee S, Strominger JL: Translocation of TCR alpha chains into the lumen of the endoplasmic reticulum and their degradation. Science 259:1901, 1993.
77. Bonifacino JS, Lippincott-Schwartz J: Degradation of proteins within the endoplasmic reticulum. Curr Opin Cell Biol 3:592, 1991.
78. Bonifacino JS, Suzuki CK, Klausner RD: A peptide sequence confers retention and rapid degradation in the endoplasmic reticulum. Science 247:790, 1990.
79. Lippincott-Schwartz J, Bonifacino JS, Yuan LC, Klausner RD: Degradation from the endoplasmic reticulum: disposing of newly synthesized proteins. Cell 54:209, 1988.
80. Redman KL, Burris GW: The cDNA for the ubiquitin-52-amino-acid fusion protein from rat encodes a previously unidentified 60 S ribosomal subunit protein. Biochem J 315:315, 1996.
81. Redman KL: The smaller protein formed as a ubiquitin fusion in Drosophila is processed from ubiquitin and found on the 60S ribosomal subunit. Insect Biochem Mol Biol 24:191, 1994.
82. Finley D, Bartel B, Varshavsky A: The tails of ubiquitin precursors are ribosomal proteins whose fusion to ubiquitin facilitates ribosome biogenesis. Nature 338:394, 1989.
83. Mitchell HK, Petersen NS, Buzin CH: Self-degradation of heat shock proteins. Proc Natl Acad Sci USA 82:4969, 1985.
84. Parag RA, Shochat Y, Kulka RG: Effect of stress on protein degradation: role of the ubiquitin system. Acta Biol Hung 42:3, 1991.
85. Mayer RJ, Lowe J, Landon M, McDermott H, Tuckwell J, Doherty F, Laszlo L: Ubiquitin and the lysosome system: molecular immunopathology reveals the connection. Biomed Biochim Acta 50:333, 1991.
86. Schirmbeck R, Reimann J: Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur J Immunol 24: 1478, 1994.
87. Srivastava PK, Udono H, Blachere NE, Li Z: Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 39:93, 1994.
88. Bevan MJ: Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 143:1283, 1976.
89. Debrick JE, Campbell PA, Staerz UD: Macrophages as accessory cells for class I MHC-restricted immune responses. J Immunol 147:2846, 1991.
90. Nair S, Buiting AM, Rouse RJ, Van Rooijen N, Huang L, Rouse BT: Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int Immunol 7:679, 1995.
91. Wu JY, Gardner BH, Kushner NN, Pozzi LA, Kensil CR, Cloutier PA, Coughlin RT, Newman MJ: Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes. Cell Immunol 154:393, 1994.
92. Kaleab B, Ottenoff T, Converse P, Halapi E, Tadesse G, Rottenberg M, Kiessling R: Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur J Immunol 20:2651, 1990.
93. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F: Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341:323, 1989.
94. da Conceicao-Silva F, Perlaza BL, Louis JA, Romero P: Leishmania major infection in mice primes for specific major histocompatibility complex class I-restricted CD8+ cytotoxic T cell responses. Eur J Immunol 24: 2813, 1994.
95. Young JW, Steinman RM: Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells. J Exp Med 171:1315, 1990.
96. Harding CV, Song R: Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol 153:4925, 1994.
97. Bohm W, Schirmbeck R, Elbe A, Melber K, Diminky D, Kraal G, van Rooijen N, Barenholz Y, Reimann J: Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J Immunol 155:331, 1995.
98. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271, 1991.
99. Reis e Sousa C, Germain RN: Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med 182:841, 1995.
100. Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C: Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3:783, 1995.
101. Aggarwal A, Kumar S, Jaffe R, Hone D, Gross M, Sadoff J: Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J Exp Med 172:1083, 1990.
102. Aldovini A, Young RA: Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 351:479, 1991.
103. Stover CK, Bansal GP, Hanson MS, Burlein JE, Palaszynski SR, Young JF, Koenig S, Young DB, Sadziene A, Barbour AG: Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med 178:197, 1993.
104. Schafer R, Portnoy DA, Brassell SA, Paterson Y: Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J Immunol 149:53, 1992.
105. Song R, Harding CV: Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J Immunol 156:4182, 1996.
106. Rock KL: A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today 17:131, 1996.
107. Kovacsovics-Bankowski M, Rock KL: A phagosome-tocytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267:243, 1995.
108. Andrews NW: From lysosomes into the cytosol: the intracellular pathway of Trypanosoma cruzi. Braz J Med Biol Res 27:471, 1994.
109. Isenman LD, Dice JF: Secretion of intact proteins and peptide fragments by lysosomal pathways of protein degradation. J Biol Chem 264:21591, 1989.
110. Dice JF: Selective degradation of cytosolic proteins by lysosomes. Ann NY Acad Sci 674:58, 1992.
111. Schirmbeck R, Reimann R: Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur J Immunol 24: 1478, 1994.
112. Pfeifer JD, Wick MJ, Harding CV, Normark SJ: Processing of defined T-cell epitopes after phagocytosis of intact bacteria by macrophages. Infect Agents Dis 2:249, 1993.
113. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV: Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359, 1993.
114. Abdel Motal UM, Zhou X, Joki A, Siddigi AR, Srinivasa BR, Stenvall K, Dahmen J, Jondal M: Major histocompatibility complex class I-binding peptides are recycled to the cell surface after internalization. Eur J Immunol 23:3224, 1993.
115. Zhou X, Liu T, Franksson L, Lederer E, Ljunggren HG, Jondal M: Characterization of TAP-independent and brefeldin A-resistant presentation of Sendai virus antigen to CD8+ cytotoxic T lymphocytes. Scand J Immunol 42:66, 1995.
116. Schirmbeck R, Melber K, Reimann J: Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur J Immunol 25:1063, 1995.
117. Sugita M, Brenner MB: Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J Biol Chem 270:1443, 1995.
118. Kubo RT, Sette A, Grey HM, Appella E, Sakaguchi K, Arnott D, Sherman N, Shabonowitz J, Michel H, Bodnar WM, Davis TA, Hunt DF: Definition of specific peptide motifs for four major HLA-A alleles. J Immunol 152: 3913, 1994.
119. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC: Identification of self-peptides bound to purified HLA-B27. Nature 353:326, 1991.
120. Harris PE, Colovai AI, Liu Z, Dalla-Favera R, Suciu-Foca N: Naturally processed MHC class I bound peptides from c-myc transfected B cells reveal allele specific motifs. J Immunol 151:5966, 1993.
121. Colovai AI, Suciu-Foca N, Baiulescu GE, Harris PE: HLA-class I self peptides isolated from a T cell leukemia reveal the allele-specific motif of HLA-B38. Tissue Antigens 44:65, 1994.
122. Harris PE, Lupu F, Hong B, Reed EF, Suciu-Foca N: Differentiation stage specific "self" peptides bound by MHC-class I molecules. J Exp Med 177:783, 1993.
123. Harris PE, Colovai AI, Maffei A, Liu Z, Suciu-Foca N: MHC class I presentation of exogenous and endogenous protein-derived peptides by a transfected human monocyte cell line. Immunology 86:601, 1995.
124. Papadopoulos KP, Colovai AI, Maffei A, Jaraquemada D, Suciu-Foca N, Harris PE: Tissue-specific MHC class I bound self peptides of a human insulinoma cell line. Diabetes 45:1761, 1996.